Jasper Net Interest Income vs Ebit Analysis

JSPR Stock

USD 22.81 0.43 1.85%

Jasper Therapeutics financial indicator trend analysis is infinitely more than just investigating Jasper Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jasper Therapeutics is a good investment. Please check the relationship between Jasper Therapeutics Net Interest Income and its Ebit accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.

Net Interest Income vs Ebit

Net Interest Income vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jasper Therapeutics Net Interest Income account and Ebit. At this time, the significance of the direction appears to have pay attention.

The correlation between Jasper Therapeutics' Net Interest Income and Ebit is -0.81. Overlapping area represents the amount of variation of Net Interest Income that can explain the historical movement of Ebit in the same time period over historical financial statements of Jasper Therapeutics, assuming nothing else is changed. The correlation between historical values of Jasper Therapeutics' Net Interest Income and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Interest Income of Jasper Therapeutics are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Net Interest Income i.e., Jasper Therapeutics' Net Interest Income and Ebit go up and down completely randomly.

Correlation Coefficient

-0.81

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Ebit

Most indicators from Jasper Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jasper Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.As of 12/01/2024, Selling General Administrative is likely to drop to about 11.2 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 61.9 M

	2010	2023	2024 (projected)
Interest Income	701K	5.2M	3.2M
Net Interest Income	701K	5.2M	3.2M

Interest Income Net Interest Income

Jasper Therapeutics fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Warrants	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Retained Earnings Total Equity	Short Term Investments	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Long Term Investments	Total Current Assets	Non Current Liabilities Other
Total Assets		0.85	0.93	0.83	0.27	-0.79	-0.78	-0.96	-0.81	0.98	1.0	0.84	0.87	0.38	1.0	0.92	-0.83	-0.53	-0.02	0.92	0.79	0.87	0.29	0.7	1.0	0.52
Other Current Liab	0.85		0.98	0.64	-0.04	-0.94	-0.91	-0.8	-0.94	0.9	0.82	0.88	0.98	0.13	0.82	0.89	-0.88	-0.63	0.14	0.9	0.68	0.88	0.45	0.86	0.83	0.1
Total Current Liabilities	0.93	0.98		0.71	0.09	-0.94	-0.91	-0.87	-0.94	0.96	0.9	0.93	0.98	0.25	0.9	0.95	-0.92	-0.6	0.11	0.95	0.78	0.9	0.44	0.8	0.91	0.28
Total Stockholder Equity	0.83	0.64	0.71		-0.11	-0.63	-0.58	-0.9	-0.73	0.73	0.85	0.6	0.62	-0.05	0.85	0.74	-0.74	-0.68	-0.51	0.73	0.68	0.89	-0.18	0.69	0.84	0.28
Other Liab	0.27	-0.04	0.09	-0.11		0.09	-0.1	-0.17	0.14	0.33	0.27	0.21	0.08	0.98	0.27	0.14	0.03	0.33	0.6	0.14	0.2	-0.13	0.54	-0.33	0.28	0.85
Net Tangible Assets	-0.79	-0.94	-0.94	-0.63	0.09		0.88	0.72	0.94	-0.82	-0.74	-0.95	-0.97	-0.08	-0.74	-0.94	0.97	0.56	-0.07	-0.94	-0.84	-0.88	-0.39	-0.71	-0.76	-0.15
Warrants	-0.78	-0.91	-0.91	-0.58	-0.1	0.88		0.8	0.95	-0.87	-0.74	-0.91	-0.94	-0.29	-0.74	-0.81	0.89	0.75	-0.32	-0.82	-0.7	-0.87	-0.64	-0.76	-0.75	-0.17
Net Debt	-0.96	-0.8	-0.87	-0.9	-0.17	0.72	0.8		0.84	-0.93	-0.96	-0.76	-0.8	-0.28	-0.96	-0.83	0.8	0.72	0.1	-0.82	-0.7	-0.92	-0.23	-0.77	-0.96	-0.4
Retained Earnings	-0.81	-0.94	-0.94	-0.73	0.14	0.94	0.95	0.84		-0.85	-0.78	-0.89	-0.94	-0.04	-0.78	-0.86	0.94	0.81	-0.04	-0.87	-0.73	-0.96	-0.39	-0.86	-0.79	-0.05
Accounts Payable	0.98	0.9	0.96	0.73	0.33	-0.82	-0.87	-0.93	-0.85		0.96	0.89	0.92	0.46	0.96	0.91	-0.84	-0.55	0.17	0.91	0.76	0.85	0.48	0.71	0.97	0.49
Cash	1.0	0.82	0.9	0.85	0.27	-0.74	-0.74	-0.96	-0.78	0.96		0.79	0.82	0.37	1.0	0.88	-0.78	-0.53	-0.06	0.88	0.73	0.85	0.24	0.7	1.0	0.51
Non Current Assets Total	0.84	0.88	0.93	0.6	0.21	-0.95	-0.91	-0.76	-0.89	0.89	0.79		0.96	0.37	0.79	0.96	-0.96	-0.49	0.23	0.96	0.91	0.84	0.53	0.57	0.81	0.42
Non Currrent Assets Other	0.87	0.98	0.98	0.62	0.08	-0.97	-0.94	-0.8	-0.94	0.92	0.82	0.96		0.25	0.82	0.94	-0.94	-0.58	0.21	0.94	0.79	0.87	0.53	0.75	0.84	0.24
Other Assets	0.38	0.13	0.25	-0.05	0.98	-0.08	-0.29	-0.28	-0.04	0.46	0.37	0.37	0.25		0.37	0.27	-0.12	0.19	0.68	0.27	0.31	0.01	0.68	-0.19	0.37	0.82
Cash And Short Term Investments	1.0	0.82	0.9	0.85	0.27	-0.74	-0.74	-0.96	-0.78	0.96	1.0	0.79	0.82	0.37		0.88	-0.78	-0.53	-0.06	0.88	0.73	0.85	0.24	0.7	1.0	0.51
Common Stock Total Equity	0.92	0.89	0.95	0.74	0.14	-0.94	-0.81	-0.83	-0.86	0.91	0.88	0.96	0.94	0.27	0.88		-0.95	-0.45	0.0	1.0	0.92	0.87	0.32	0.62	0.9	0.45
Retained Earnings Total Equity	-0.83	-0.88	-0.92	-0.74	0.03	0.97	0.89	0.8	0.94	-0.84	-0.78	-0.96	-0.94	-0.12	-0.78	-0.95		0.62	0.02	-0.95	-0.91	-0.93	-0.33	-0.67	-0.8	-0.27
Short Term Investments	-0.53	-0.63	-0.6	-0.68	0.33	0.56	0.75	0.72	0.81	-0.55	-0.53	-0.49	-0.58	0.19	-0.53	-0.45	0.62		0.11	-0.45	-0.33	-0.81	-0.19	-0.85	-0.53	0.24
Non Current Liabilities Total	-0.02	0.14	0.11	-0.51	0.6	-0.07	-0.32	0.1	-0.04	0.17	-0.06	0.23	0.21	0.68	-0.06	0.0	0.02	0.11		0.01	-0.05	-0.18	0.93	-0.11	-0.05	0.18
Capital Surpluse	0.92	0.9	0.95	0.73	0.14	-0.94	-0.82	-0.82	-0.87	0.91	0.88	0.96	0.94	0.27	0.88	1.0	-0.95	-0.45	0.01		0.92	0.87	0.33	0.62	0.89	0.44
Other Current Assets	0.79	0.68	0.78	0.68	0.2	-0.84	-0.7	-0.7	-0.73	0.76	0.73	0.91	0.79	0.31	0.73	0.92	-0.91	-0.33	-0.05	0.92		0.78	0.23	0.35	0.76	0.58
Other Stockholder Equity	0.87	0.88	0.9	0.89	-0.13	-0.88	-0.87	-0.92	-0.96	0.85	0.85	0.84	0.87	0.01	0.85	0.87	-0.93	-0.81	-0.18	0.87	0.78		0.19	0.83	0.86	0.16
Total Liab	0.29	0.45	0.44	-0.18	0.54	-0.39	-0.64	-0.23	-0.39	0.48	0.24	0.53	0.53	0.68	0.24	0.32	-0.33	-0.19	0.93	0.33	0.23	0.19		0.2	0.26	0.23
Long Term Investments	0.7	0.86	0.8	0.69	-0.33	-0.71	-0.76	-0.77	-0.86	0.71	0.7	0.57	0.75	-0.19	0.7	0.62	-0.67	-0.85	-0.11	0.62	0.35	0.83	0.2		0.7	-0.24
Total Current Assets	1.0	0.83	0.91	0.84	0.28	-0.76	-0.75	-0.96	-0.79	0.97	1.0	0.81	0.84	0.37	1.0	0.9	-0.8	-0.53	-0.05	0.89	0.76	0.86	0.26	0.7		0.52
Non Current Liabilities Other	0.52	0.1	0.28	0.28	0.85	-0.15	-0.17	-0.4	-0.05	0.49	0.51	0.42	0.24	0.82	0.51	0.45	-0.27	0.24	0.18	0.44	0.58	0.16	0.23	-0.24	0.52

Click cells to compare fundamentals

Jasper Therapeutics Account Relationship Matchups

Pair Trading with Jasper Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Jasper Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Jasper Stock

0.56	HCM	HUTCHMED DRC	Pair Corr
0.47	ZTS	Zoetis Inc	Pair Corr
0.4	LLY	Eli Lilly	Pair Corr
0.39	RDY	Dr Reddys Laboratories	Pair Corr
0.37	PFE	Pfizer Inc Aggressive Push	Pair Corr

The ability to find closely correlated positions to Jasper Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jasper Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jasper Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jasper Therapeutics to buy it.

The correlation of Jasper Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Jasper Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Jasper Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Jasper Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Jasper Net Interest Income vs Ebit Analysis

Net Interest Income vs Ebit

Net Interest Income vs Ebit Correlation Analysis

Correlation Coefficient

Net Interest Income

Ebit

Jasper Therapeutics fundamental ratios Correlations

Jasper Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pair Trading with Jasper Therapeutics

Moving against Jasper Stock

Additional Tools for Jasper Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments

Non Currrent Assets Other	- 0.97	Net Tangible Assets
Retained Earnings Total Equity	- 0.96	Non Current Assets Total
Other Stockholder Equity	- 0.96	Retained Earnings
Total Current Assets	- 0.96	Net Debt
Cash And Short Term Investments	- 0.96	Net Debt
Cash	- 0.96	Net Debt